Aliases: None
Indications: V-Fib or Pulseless V-Tach(pVT) Cardiac Arrest, Wide Complex Tachycardia with a Pulse, All Torsade de Pointes, Respiratory Distress or Failure, OB Seizures (eclampsia)
Contraindications: Hypotension, third degree AV block, routine dialysis patients, known hypocalcemia
Concentrations:
Injection: 500 mg/mL
Dosing
Adult:
Indication | Dose | Route | Note |
V-fib or pVT Cardiac Arrest | 2 g | Slow IV Push | Refractory VF/pVT only |
-Tachycardia with a Pulse: -AFib/AFlutter with RVR -Torsades de Pointes -Respiratory Distress/Failure | 2 g | IV Infusion over 5 minutes | |
OB Seizures | 4 g | IV Infusion over 5 minutes | |
Pediatric:
Indication | Dose | Route | Note |
V-fib or pVT Cardiac Arrest | 50 mg/kg Max: 2 g | Slow IV Push | Refractory VF/pVT only |
-Wide Complex Tachycardia WITH a Pulse (Torsades de Pointes) -Respiratory Distress/Failure | 50 mg/kg Max: 2 g | IV Infusion over 5 minutes |
Precautions: Magnesium Sulfate should be administered slowly to minimize side effects. Use with caution in patients with known renal insufficiency. In hypermagnesemia Calcium Chloride should be available as an antidote if serious side effects occur
Adverse/Side Effects: Hypotension, cardiac arrest, respiratory/CNS depression, flushing, sweating, bradycardia, decreased deep tendon reflexes, drowsiness, respiratory depression, arrhythmia, hypothermia, itching, and rash.
Class: Antiarrhythmic (Class V), Electrolyte
Mechanism of Action: Magnesium Sulfate is a salt that dissociates into the Magnesium cation and the sulfate anion. Magnesium is an essential element in numerous biochemical reactions that occur within the body. Magnesium Sulfate acts as a calcium channel blocker and blocks neuromuscular transmission. Hypomagnesemia can cause refractory ventricular fibrillation. Magnesium Sulfate is also a central nervous system depressant used for seizures associated with eclampsia and it is also a bronchodilator.
Onset of Action | Peak Effect | Duration of Action |
Immediate | Fast | 30 minutes |